Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Athersys Company Profile

02:46 EDT 17th April 2014 | BioPortfolio

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.

Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.


3201 Carnegie Avenue
United States of America


Phone: 216-431-9900
Fax: 216-361-9495

News Articles [48 Associated News Articles listed on BioPortfolio]

Stem cell company Athersys eyes potential new opportunities for its stroke therapy in Japan

Athersys (NYSE:ATHX) is looking to Japan for potential opportunities to bring its MultiStem therapies to market quicker. In its annual financial results call on Thursday, Athersys’ chief operati...

Recent Developments Do Not Justify Athersys' Doubling Since December

ByLouis Dematteis:Since early December, Athersys, Inc. (ATHX) is up more than 100%, with the company doubling in value from a little over $120M to its current capitalization of $240M. In an effort to...

Athersys: Two Crucial Near-Term Events

By JDT Investments:Athersys (ATHX) is a clinical stage biotech company focused primarily on its proprietary "Off-the-Shelf" stem cell product called Multistem. In a previous article I took a comprehen...

Athersys: Pfizer Completes Patient Enrollment In Phase II MultiStem Cell Therapy

NEW YORK CITY (dpa-AFX) - Athersys Inc. (ATHX) Thursday said Pfizer Inc.(PFE) has completed patient enrollment of a Phase II study that involves the administration of Athersys' MultiStem cell ther...

A Comprehensive Look At Athersys

By U.S. Biotech Investor: Financial Biotechnology investors may want to take a look at Athersys, Inc. (ATHX) a quiet leader in the regenerative medicine field with a meager $308 million market cap....

Athersys nets $19.1mm via RDO

Athersys Inc. (uses regenerative medicine to treat various conditions) netted $19.1mm through the sale of 5mm common shares at $4.10 each (a 38% premium) to returning shareholders. The company also is...

BRIEF-Athersys up 13.5 percent premarket

NEW YORK, Dec 17 (Reuters) - Athersys Inc : * Up 13.5 percent to $2.31 in premarket; says stem cell therapy gets orphan drug designation in Europe for prevention of graft-versus-host disease

Athersys raises $20.5 million in direct offering

Athersys Inc. (NASDAQ:ATHX) raised $20.5 million through the sale of 5 million units at $4.10 in a registered direct offering to institutional investors. Each unit comprises a share and a warrant to p...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]


Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company...

More Information about "Athersys" on BioPortfolio

We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record